4Sheila C. Dollard, Scott D. Grosse and Danielle S. Ross.New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infectiony [J]. Wiley Inter Science, 2007.6 : 355-363.
5Biron KK. Antiviral drugs for cytomegalovirus diseases [J]. Antiviral Rea, 2006,71(2-3): 154-163.
6Cesaro S, BoaroM P. Immunerecon stitution complicated by CMV retinitis in a pediatric patient who under went haplo identical CD34+ selected hematopoiet ic stem cell transplant for acutely mphoblast icleukemia[J]. Int JHematoJ, 2008, 8( 4 ): 153-155.
7Vaneikovd Z, Kucerovd T, Peliktn L,et al. Perinatal cytomegalovirus hepatitis:to treat or not to treat with ganeielovir[J]. Paediatr Child Health, 2004,40: 444-448.
8Kimberlin D, Acosta EP, Sanehez P, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease [J]. Infect Dis,2008,197 : 836-45.
9lmbardi G, Garofili F, Vilani P, et al. Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection [J]. Eu J Chn Microbiol Dis, 2009,28(12) : 14,65-70.
